| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 975,100 | 932,800 | 778,000 | 918,000 | | Cost of Revenue | 1,079,400 | 922,500 | 720,200 | 816,600 | | | Gross Profit | (104,300) | 10,300 | 57,800 | 101,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 76,300 | 152,400 | 144,100 | 150,200 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (180,600) | (142,100) | (86,300) | (48,800) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,000 | 600 | 6,700 | 13,800 | | Earnings Before Interest And Taxes | (199,000) | (141,500) | (79,600) | (35,000) | | Interest Expense | 27,100 | 20,400 | 23,400 | 26,300 | | Income Before Tax | (226,100) | (161,900) | (103,000) | (61,300) | | Income Tax Expense | 5,800 | (19,600) | 5,500 | 1,300 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (228,000) | (142,300) | (108,500) | (62,600) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (231,900) | (142,300) | (108,500) | (62,600) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($231,900) | ($142,300) | ($108,500) | ($62,600) |
|
0.31% Nasdaq 
0.05%
Income Statement
